Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results
Acq. announced
Asset disposition

CLINICAL DATA INC (CLDA) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/02/2011 BW The Law Offices of Vincent Wong Announce an Investigation into Possible Breaches of Fiduciary Duty by the Board of Clinical Data, Inc. in Connection with the Sale of the Company to Forest Laboratories, Inc. – CLDA
03/02/2011 BW Brower Piven Announces an Investigation of the Acquisition of Clinical Data, Inc. by Forest Laboratories, Inc.
02/25/2011 BW Goldman Scarlato & Karon, P.C. Announces Investigation of Clinical Data, Inc.
02/25/2011 BW Bull & Lifshitz, LLP Announces Investigation of the Acquisition of Clinical Data, Inc.
02/23/2011 BW Clinical Data, Inc. Shareholder Investigation by Briscoe Law Firm Concerning Acquisition by Forest Laboratories, Inc.
02/23/2011 BW Ryan & Maniskas, LLP Announces Investigation of Clinical Data, Inc.
02/22/2011 BW The Law Office of Abe Shainberg Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Clinical Data, Inc. in Connection with the Sale of the Company to Forest Laboratories, Inc. – CLDA
02/22/2011 BW Robbins Umeda LLP Is Investigating Clinical Data, Inc. Acquisition for Shareholders
02/22/2011 BW Faruqi & Faruqi, LLP Announces Shareholder Investigation Related to the Acquisition of Clinical Data, Inc. - CLDA
02/22/2011 BW Finkelstein Thompson LLP Announces Investigation of Clinical Data, Inc.
02/22/2011 BW Kendall Law Group Investigates Clinical Data, Inc. for Shareholders
02/22/2011 BW Rigrodsky & Long, P.A. Investigates Buyout of Clinical Data, Inc. - CLDA
02/22/2011 BW Harwood Feffer LLP Announces Investigation of Clinical Data, Inc.
02/22/2011 BW The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Clinical Data, Inc. in Connection with the Sale of the Company to Forest Laboratories, Inc. – CLDA
12/08/2010 BW Clinical Data, Inc. Announces Vilazodone Data Presented at American Society of Health System Pharmacists
12/08/2010 BW Clinical Data, Inc. to Present at Deutsche Bank's 2010 BioFEST
11/29/2010 BW Clinical Data, Inc. to Sell FAMILION® Testing and Pharmacogenomics Biomarker Development Business for $15.4 Million Plus Potential Milestones, Royalties and other Consideration
11/23/2010 BW Clinical Data, Inc. to Present at the 22nd Annual Piper Jaffray Health Care Conference
11/22/2010 BW Clinical Data, Inc. Announces Vilazodone Data Featured at the 2010 U.S. Psychiatric & Mental Health Congress
11/15/2010 BW Clinical Data, Inc. Files Shelf Registration Statement
11/09/2010 BW Clinical Data, Inc. Reports Second Quarter Fiscal Year 2011 Operational and Financial Results
11/08/2010 BW Clinical Data, Inc. Launches FAMILION® Genetic Tests for Left Ventricular Noncompaction and Long QT Syndrome Large Deletion/Duplication Mutations
11/05/2010 BW Clinical Data, Inc. Receives Therapeutic Discovery Project Grants
11/01/2010 BW Clinical Data, Inc. Granted Orphan Drug Designation for PRX-8066 for Pulmonary Arterial Hypertension
10/14/2010 BW Clinical Data, Inc. to Present at the Newsmakers in the Biotech Industry Conference
10/04/2010 BW Clinical Data, Inc. Launches FAMILION® Genetic Test for Medical Examiners to Aid in Determining the Cause of Sudden Unexplained Death and Sudden Infant Death Syndrome
09/24/2010 BW Clinical Data, Inc. Presents Data from Phase I Studies of Stedivaze™ Demonstrating Safety and Tolerability in Patients with Asthma and COPD
09/21/2010 BW Clinical Data, Inc. to Present at the JMP Securities Healthcare Conference
08/09/2010 BW Clinical Data, Inc. Reports First Quarter Fiscal Year 2011 Operational and Financial Results
07/29/2010 BW Clinical Data, Inc. to Present at Upcoming Investor Conferences
06/14/2010 BW Clinical Data, Inc. Announces Closing of $32.0 Million Public Offering Including Full Exercise of Over-Allotment
06/14/2010 BW Clinical Data, Inc. Reports Fourth Quarter and Fiscal Year 2010 Results
06/09/2010 BW Clinical Data, Inc. Prices Public Offering of Common Stock
06/08/2010 BW Clinical Data, Inc. Announces Public Offering of Common Stock
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy